Damon Runyon Clinical Investigator Award Continuation Grant

Quick Links:

Overview | Funding | Eligibility | Terms of the Award | Key Dates | Continuation Grant
Application Guidelines | Forms

Program Description

NOTICE: The 2019 application deadline is Friday, March 15.

The Damon Runyon Clinical Investigator Award Continuation Grant is designed to provide two additional years of support to Damon Runyon Clinical Investigators who are approaching the end of their awards and need extra time and funding to complete a promising avenue of research, or initiate/continue a clinical trial.


All third-year Damon Runyon Clinical Investigators are eligible to apply.


The $300,000 grant will be for a period of two years. Funding in the amount of $150,000 will be allocated to the awardee’s institution each year for the support of the Clinical Investigator. Funds are intended to be flexible and can be used for a variety of scientific needs including the Investigator’s salary, salaries for professional and technical personnel, special equipment, supplies, and other miscellaneous items required to conduct the proposed research. No part of this grant can be used for indirect costs or institutional overhead.

Other Funding
Investigators may receive funding from other sources to support their research.  However, no other physician-scientist career development award from a private source (non-federal government) may be held concurrently with the Damon Runyon Clinical Investigator Award Continuation Grant.

Physician-scientist career development awards from the federal government including the National Institutes of Health (e.g., K-08, K-12, K-23), the Department of Defense, and the U.S. Department of Veterans Affairs are allowed.

Scientific or budgetary overlap with other funded projects is not allowed.  Therefore, it is critical that all current and pending grant support for your research be reported to the Foundation and the relationship of that support to the Damon Runyon funded project be explained.

Please contact the Foundation with any questions regarding concurrent funding (212.455.0520).


The Clinical Investigator Award Committee will review applications and select awardees for approval by the Damon Runyon Cancer Research Foundation’s Board of Directors.

Selection Criteria

The Clinical Investigator must demonstrate the following:

High productivity and significant accomplishments during his/her first three years of funding; and that additional funding would enable either the completion of a promising avenue of research, or initiation or continuation of a clinical trial, and that the Clinical Investigator has insufficient funding for the proposed research; and that the research to be funded has the potential to impact the prevention, diagnosis or treatment of one or more forms of cancer.

How to Apply

All application materials should be emailed to clare.cahill@damonrunyon.org on or before the March 15, 2019 deadline. 

The complete application should be assembled in the following order:

  1. Application Cover Sheet
    Please fill in all required information on the provided form and make sure all signatures are in place.

  2. Research Proposal
    In total, no longer than five pages of single spaced, 12-point type and should include:

    • A summary of your progress and accomplishments under your current Damon Runyon Clinical Investigator Award. (~ 2 pages)
    • Description of your proposed research. (~ 2 pages)
    • A compelling justification for additional funding based on the criteria outlined under “Selection Criteria” section. (~ 1 page)
  3. Mentor’s Letter of Support
    The Mentor should evaluate the applicant’s progress in becoming an independent clinical investigator and support his/her need for additional funding. [If the applicant has a co-mentor, he/she should write an additional letter, or the mentors can write one letter in conjunction.]

  4. Applicant’s NIH Biosketch
    This should include education and training information, research and professional experience, and a bibliography of the candidate. In the bibliography, (1) the candidate’s name must be highlighted for each entry, (2) original, peer-reviewed research articles must be listed separately and first, (3) and next list review articles, chapters, editorials, etc. (Do not include presentations, abstracts, or “in preparation” or “under review” articles.)

  5. Other Sources of Funding
    A list of all current and pending funding sources, including the specific aims of each grant and the degree of overlap with the applicant’s proposal. (Please note: Scientific or budgetary overlap with other funded projects is not allowed.)

  6. Budget
    The budget should be realistic estimates of the funds required for the proposed research and should also be itemized by category according to the instructions on the budget form.

  7. Human Subjects, Radiation Safety and Environmental Health Issues Statement
    A written statement testifying that adequate safety precautions will apply for projects that involve any biohazards (e.g., recombinant DNA, chemical carcinogens, etc.) and that the research project has been (or will be) approved by the appropriate Institutional Review Board, Institutional Animal Care and Use Committee, and/or Biohazards Committee.

Policies and Procedures

All Clinical Investigator Award policies and procedures will apply to the Continuation Grant.

Contact Information

Award Programs | 212.455.0520 | awards@damonrunyon.org